Abstract
Loeys-Dietz syndrome (LDS) represents a clinically and genetically heterogeneous group of connective tissue disorders that share features similar to Marfan syndrome, first identified in 2005. Characterized by significant manifestations, such as aortic aneurysms, arterial tortuosity, craniofacial and skeletal anomalies, LDS results from pathogenic variants in key genes of the transforming growth factor-beta signaling pathway. Given its variable expressivity, a multidisciplinary approach to management is critical. The article provides an updated overview of effective management practices since the first LDS primer in 2014. It aims to enhance clinical awareness, inform health care providers, and improve patient outcomes through individualized care strategies for those living with LDS.
| Original language | English |
|---|---|
| Article number | 102577 |
| Journal | Genetics in Medicine |
| Volume | 28 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2026 |
Bibliographical note
Publisher Copyright:© 2026 The Authors.
Fingerprint
Dive into the research topics of 'Loeys-Dietz syndrome: 2026 updated care management primer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver